Proven technology1

The LINQ™ family of ICMs (Reveal LINQ™ ICM and LINQ II™ ICM) has been featured in 1,000+ published clinical articles and abstracts.

Read a large, real-world cohort analysis of arrhythmia detection and therapeutic interventions in patients with insertable cardiac monitors2.



Medtronic-sponsored clinical trials

CRYSTAL-AF study3

Read about how the CRYSTAL-AF study showed that the Reveal LINQ™ ICM is superior to standard monitoring for atrial fibrillation (AF) detection in cryptogenic stroke patients.

STROKE AF study4

Review the STROKE AF study that showed that the Reveal LINQ™ ICM is superior to site-specific usual care for AF detection in large- and small-vessel stroke patients.

PICTURE study5

Learn about the clinical impact of this study, which evaluated Reveal™ ICM use in patients with unexplained syncope.


REVEAL AF study6

Explore the results of this study, which evaluated continuous, long-term monitoring with Reveal LINQ™ ICM for patients at high risk for AF and stroke.



Related products